<VariationArchive VariationID="225630" VariationName="NM_021076.4(NEFH):c.3010_3011del (p.Asp1004fs)" VariationType="Deletion" Accession="VCV000225630" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2016-06-26" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="227464" VariationID="225630">
      <GeneList>
        <Gene Symbol="NEFH" FullName="neurofilament heavy chain" GeneID="4744" HGNC_ID="HGNC:7737" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29480218" stop="29491390" display_start="29480218" display_stop="29491390" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29876180" stop="29887278" display_start="29876180" display_stop="29887278" Strand="+" />
          </Location>
          <OMIM>162230</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_021076.4(NEFH):c.3010_3011del (p.Asp1004fs)</Name>
      <CanonicalSPDI>NC_000022.11:29490648:AGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="29490649" stop="29490650" display_start="29490649" display_stop="29490650" variantLength="2" positionVCF="29490648" referenceAlleleVCF="AAG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="29886638" stop="29886639" display_start="29886638" display_stop="29886639" variantLength="2" positionVCF="29886637" referenceAlleleVCF="AAG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>D1004fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.29886639_29886640del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.29886639_29886640del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.29490650_29490651del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.29490650_29490651del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008404.1" sequenceAccession="NG_008404" sequenceVersion="1" change="g.15459_15460del">
            <Expression>NG_008404.1:g.15459_15460del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021076.4" sequenceAccession="NM_021076" sequenceVersion="4" change="c.3010_3011del" MANESelect="true">
            <Expression>NM_021076.4:c.3010_3011del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066554.2" sequenceAccession="NP_066554" sequenceVersion="2" change="p.Asp1004fs">
            <Expression>NP_066554.2:p.Asp1004fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10576036" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="162230.0002" DB="OMIM" />
        <XRef Type="rs" ID="876657411" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021076.4(NEFH):c.3010_3011del (p.Asp1004fs) AND Charcot-Marie-Tooth disease axonal type 2CC" Accession="RCV000210935" Version="3">
        <ClassifiedConditionList TraitSetID="26614">
          <ClassifiedCondition DB="MedGen" ID="C4310790">Charcot-Marie-Tooth disease axonal type 2CC</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-06-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_021076.4(NEFH):c.3010_3011del (p.Asp1004fs) AND not provided" Accession="RCV001853394" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-06-26" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27040688</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29587262</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30992180</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="26614" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="35311" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2CC</ElementValue>
                <XRef Type="MIM" ID="616924" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease axonal type 2CC</ElementValue>
                <XRef ID="MONDO:0014836" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT2CC</ElementValue>
                <XRef Type="MIM" ID="616924" DB="OMIM" />
              </Symbol>
              <XRef ID="C4310790" DB="MedGen" />
              <XRef ID="MONDO:0014836" DB="MONDO" />
              <XRef Type="MIM" ID="616924" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="501951" SubmissionDate="2016-06-24" DateLastUpdated="2016-06-26" DateCreated="2016-05-01">
        <ClinVarSubmissionID localKey="162230.0002_CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC" title="NEFH, 2-BP DEL, 3010GA  _CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC" />
        <ClinVarAccession Accession="SCV000267619" DateUpdated="2016-06-26" DateCreated="2016-05-01" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a British family (UK1) with autosomal dominant axonal Charcot-Marie-Tooth disease type 2CC (CMT2CC; 616924), Rebelo et al. (2016) identified a heterozygous 2-bp deletion (c.3010_3011delGA) in exon 4 of the NEFH gene, resulting in a frameshift and premature termination (Asp1004GlnfsTer58). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. The mutation affects the last coding exon and shifts translation into an alternative reading frame, resulting in continued translation of an additional 40 amino acids beyond the stop codon. The mutation was filtered against the Exome Variant Server database and was not found in 5,200 exomes from additional individuals with a wide range of clinical phenotypes, including other neuropathies. The extra amino acids at the 3-prime end of the protein resulted in the addition of cryptic amyloidogenic elements (CAE) with a high propensity to form toxic aggregates.</Attribute>
              <Citation>
                <ID Source="PubMed">27040688</ID>
              </Citation>
              <XRef DB="OMIM" ID="616924" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEFH" />
          </GeneList>
          <Name>NEFH, 2-BP DEL, 3010GA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 3010GA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="162230.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4197325" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4962933|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002179405" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29587262</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30992180</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27040688</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27040688</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the NEFH protein. Other variant(s) that result in a similarly extended protein product (p.Lys1020Glufs*43) have been determined to be pathogenic (PMID: 29587262, 30992180; Invitae). This suggests that these extensions are likely to be disease-causing. Experimental studies have shown that this frameshift affects NEFH function (PMID: 27040688). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 225630). This frameshift has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 27040688). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the NEFH gene (p.Asp1004Glnfs*58). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 17 amino acid(s) of the NEFH protein and extend the protein by 40 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEFH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.29886638_29886639del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="501951" TraitType="Disease" MappingType="Name" MappingValue="CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC" MappingRef="Preferred">
        <MedGen CUI="C4310790" Name="Charcot-Marie-Tooth disease axonal type 2CC" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4197325" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

